AOB COHORT 13

Back to Athena on Boards

Athena on Boards | Cohort 13

February - June 2024 | POWERED BY DLA PIPER

Elise Bradley

Senior Director, Technical Operations CMC

Mirati Therapeutics (BMS)

Fiona Carleton

Executive Director CMC Manufacturing and Project Management

DMK Pharmaceuticals

Cara Casseday

President and CEO

Casseday Clinical Consulting.

Jill Collins

CEO + Chief Strategy Officer

Audacity Health

Christine Esau

Vice President, Biology

Arrowhead Pharmaceuticals

Morassa Mohseni

Vice President, Scientific Operations

Encodia

Rebecca Nugent

VP, HTP Operations

Tessera Therapeutics

Andrea (Andy) Paz

SVP/GM

Experian (Former)

Diane Retallack

President and Chief Operating Officer

Primrose Bio, Inc.

Jackie Starrett

Associate Director, Research

Tyra Biosciences

Jila T'Kanchi

Director of Software Development

Intuit, Inc.

Simone Ward

Executive Legal, Intellectual Property Counsel

Arcturus Therapeutics, Inc.

Contact Athena CEO, Holly Smithson to secure your spot on the waitlist

for the next cohort and design your board search through Athena’s On Board Series.

Athena on Boards | Mentors

Amy Anuk

Limited Partner

Beyond Capital Ventures

Anna Spence

Athena on Boards Committee

This is placeholder text. To connect this element to content from your collection, select the element and click Connect to Data.

Shirin Alipanah

Technology Partner